Trial intelligence / Profile preview

Sativex and THC in intractable cancer-related pain

NCT00674609Phase 3Completed

Sponsor
Jazz Pharmaceuticals plc
Start
Feb 2002
Primary completion
Feb 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cannabis extract, dronabinol in cancer pain, sponsored by Jazz Pharmaceuticals plc. Started Feb 2002; status: completed.

02

Drugs

cannabis extractdronabinol
03

Conditions

cancer pain

Beyond the preview

Go deeper on NCT00674609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00674609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call